2021. Potential therapy with the inhibitor of TGF-β receptors LY2109761 for oral squamous cell carcinoma. Research, Society and Development. 10, 9 (Aug. 2021), e54810918396. DOI:https://doi.org/10.33448/rsd-v10i9.18396.